基于18F-FDG PET/CT的深度学习影像组学预测乳腺癌新辅助化疗未达病理完全缓解后5年无病生存
本研究回顾性纳入105例新辅助化疗后未达病理完全缓解的乳腺癌患者,中位随访71个月,15例复发、7例死亡。从原发肿瘤提取3644个影像组学特征和4096个深度特征,采用Cox回归构建模型,整合RCB、cT及影像组学和深度特征的联合模型预测5年DFS的AUC在训练组为0.943、验证组为0.938。
要点
- 联合模型预测5年DFS的AUC训练组0.943、验证组0.938。
- RCB、cT、4个影像组学特征和7个深度特征为DFS显著预测因子。
- 中位随访71个月,105例中15例复发、7例死亡。
核心结论
- 整合PET/CT影像组学与深度特征的联合模型可准确预测非pCR患者的5年DFS,有助于识别高复发风险患者并加强辅助治疗以改善生存。
研究设计与样本
- 回顾性纳入105例新辅助化疗后未达病理完全缓解的乳腺癌患者,从原发肿瘤提取3644个影像组学特征和4096个深度特征,采用Cox回归筛选特征并构建Cox比例风险模型预测DFS。
主要发现
- 中位随访71个月,15例复发、7例死亡。
- RCB、cT、4个影像组学特征和7个深度特征为DFS的显著预测因子并纳入建模。
- 整合RCB、cT及PET/CT影像组学和深度特征的联合模型预测5年DFS的AUC在训练组为0.943、验证组为0.938。
临床怎么用
- 作者认为该联合模型可帮助识别高复发风险的非pCR患者,并加强辅助治疗以改善生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to assess whether a combined model incorporating radiomic and depth features extracted from PET/CT can predict disease-free survival (DFS) in patients who failed to achieve pathologic complete response (pCR) after neoadjuvant chemotherapy. RESULTS: This study retrospectively included one hundred and five non-pCR patients. After a median follow-up of 71 months, 15 and 7 patients experienced recurrence and death, respectively. The primary tumor volume underwent feature extraction, yielding a total of 3644 radiomic features and 4096 depth features. The modeling procedure employed Cox regression for feature selection and utilized Cox proportional-hazards models to make predictions on DFS. Time-dependent receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) were utilized to evaluate and compare the predictive performance of different models. 2 clinical features (RCB, cT), 4 radiomic features, and 7 depth features were significant predictors of DFS and were included to develop models. The integrated model incorporating RCB, cT, and radiomic and depth features extracted from PET/CT images exhibited the highest accuracy for predicting 5-year DFS in the training (AUC 0.943) and the validation cohort (AUC 0.938). CONCLUSION: The integrated model combining radiomic and depth features extracted from PET/CT images can accurately predict 5-year DFS in non-pCR patients. It can help identify patients with a high risk of recurrence and strengthen adjuvant therapy to improve survival.
引用
- Zheng X, Huang Y, Lin Y, et al. 18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer. EJNMMI Res. 2023. PMID: 38052965. doi:10.1186/s13550-023-01053-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。